Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)

Saved in:
Bibliographic Details
Published in:Journal of Hepatocellular Carcinoma
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871475375917236225
collection WordPress RSS
FRELIP Feed Integration
container_title Journal of Hepatocellular Carcinoma
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:105463
institution FRELIP
journal_source_facet Journal of Hepatocellular Carcinoma
last_indexed 2026-07-23T03:39:59.775Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
title_alt Sintilimab adyuvante más bevacizumab después de la resección curativa del carcinoma hepatocelular con rotura espontánea: Protocolo para un estudio prospectivo, exploratorio, de un solo brazo (CLEAR-2)
Sintilimab adjuvant plus bévacizumab après résection curative d'un carcinome hépatocellulaire rompu spontanément : protocole pour une étude prospective, exploratoire, à un seul bras (CLEAR-2)
Sintilimabe Adjuvante Mais Bevacizumabe Após Ressecção Curativa de Carcinoma Hepatocelular com Ruptura Espontânea: Protocolo para um Estudo Prospectivo, Exploratório, de Braço Único (CLEAR-2)
title_auth Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
title_es_txt Sintilimab adyuvante más bevacizumab después de la resección curativa del carcinoma hepatocelular con rotura espontánea: Protocolo para un estudio prospectivo, exploratorio, de un solo brazo (CLEAR-2)
title_fr_txt Sintilimab adjuvant plus bévacizumab après résection curative d'un carcinome hépatocellulaire rompu spontanément : protocole pour une étude prospective, exploratoire, à un seul bras (CLEAR-2)
title_full Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
title_fullStr Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
title_full_unstemmed Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
title_pt_txt Sintilimabe Adjuvante Mais Bevacizumabe Após Ressecção Curativa de Carcinoma Hepatocelular com Ruptura Espontânea: Protocolo para um Estudo Prospectivo, Exploratório, de Braço Único (CLEAR-2)
title_short Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
title_sort adjuvant sintilimab plus bevacizumab after curative resection of spontaneously ruptured hepatocellular carcinoma: protocol for a prospective, exploratory, single-arm study (clear-2)
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://www.dovepress.com/adjuvant-sintilimab-plus-bevacizumab-after-curative-resection-of-spont-peer-reviewed-fulltext-article-JHC